Schroders Capital invests in Neurona Therapeutics to advance neural cell therapies
In a significant development for the life sciences sector, Schroders Capital Global Innovation Trust plc has announced a strategic investment of $1.6 million (£1.3 million) in Neurona Therapeutics, a leading US-based clinical-stage cell therapy company. This investment was part of Neurona’s Series E financing round, which successfully raised $120 million. The round was co-led by […]
